ASCO® 2026 Highlights: Presenter Vignette – Elizabeth Nally

Dr. Elizabeth Nally

Elizabeth Nally

MBBS, BSc

Barts Cancer Institute

4512

Decision regret and toxicity perception following adjuvant pembrolizumab in renal cell carcinoma.